UK doctors, struggling to give advice to women on alternatives to
hormone replacement therapy (HRT), are launching a study to find
out how effective red clover is at preventing the hot flushes
experienced during menopause.
Novogen is blaming lower US sales of its red clover-based
supplements in the first six months of 2004 on consumer confusion
due to the conflicting publicity regarding the safety and efficacy
of HRT and natural menopause products.
Shares in Australian isoflavone specialist Novogen climbed more
than 3 per cent this week on news that the firm had settled a
patent dispute with the leading US supplements retailer GNC over
its red clover product.